Commented Articles

PanNASH covers commented articles ans publications to acquire sufficient information, understanding, and skills to cope with NASH/NAFLD healthcare demands.

Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date.

Authors: Albhaisi S, Sanyal AJ.
Published in Pharmaceutical Medicine, 2019
To date, histological assessment of the liver using liver biopsy has served as the reference standard for evaluation of the presence and severity of NAFLD as well as for the assessment of disease progression or regression. Non-invasive tests to evaluate fibrosis rely on either changes in the physical properties...
Read MoreApplying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date.

DNA Hydroxymethylation at the Interface of the Environment and Nonalcoholic Fatty Liver Disease.

Authors: Tommasi S, Besaratinia A.
Published in Int J Environ Res Public Health. 2019
NAFLD is a multi-faceted disease with metabolic, genetic, epigenetic, and environmental determinants. An increasing number of studies has also provided evidence for the role of xenobiotics in the genesis of steatosis...
Read MoreDNA Hydroxymethylation at the Interface of the Environment and Nonalcoholic Fatty Liver Disease.

Evaluation of Dietary Approaches for the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review.

Authors: Saeed N, Nadeau B, Shannon C, et al.
Published in Nutrients.
The optimal nutritional approach to treat NAFLD remains unclear. N. Saeed et al. (Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor) conducted a systematic...
Read MoreEvaluation of Dietary Approaches for the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review.

Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease.

Authors: Sookoian S, Salatino A, Castano GO, et al.
Published in Gut 2020
Silvia Sookoian et al. (Institute of Medical Research A Lanari, University of Buenos Aires Faculty of Medicine, Buenos Aires, Argentina) aimed to characterise the liver tissue bacterial metataxonomic signature in two independent...
Read MoreIntrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease.

Does SEN-V and other non-A-E hepatotropic viruses contribute to the development and progression of non-alcoholic fatty liver disease?

Authors: Grubert Van Iderstine M, Osiowy C, Rumbolt C, et al.
Published in Med Hypotheses 2019;137:109528.
Approximately 10-20% of patients with non-alcoholic fatty liver disease (NAFLD) are at risk of progressing to cirrhosis. The cause of such progression is unclear. SEN-V is a hepatotropic virus that has been associated with more severe...
Read MoreDoes SEN-V and other non-A-E hepatotropic viruses contribute to the development and progression of non-alcoholic fatty liver disease?

Pediatric Fatty Liver Disease: reports of NAFLD in patients as young as 2 years of age documented in an article by Dr Ajay Jain, Department of Pediatrics, saint louis university, in the USA.. have been

Pediatric Fatty Liver Disease: reports of NAFLD in patients as young as 2 years of age documented in an article by Dr Ajay Jain, Department of Pediatrics, saint louis university, in the USA..
Read MorePediatric Fatty Liver Disease: reports of NAFLD in patients as young as 2 years of age documented in an article by Dr Ajay Jain, Department of Pediatrics, saint louis university, in the USA.. have been

Advancing the understanding of NAFLD to hepatocellular carcinoma development: From experimental models to humans.

Authors: Chen K, Ma J, Jia X, et al.
Published in Biochim Biophys Acta Rev Cancer 2019;1871:117-125.
Nonalcoholic fatty liver disease (NAFLD) has recently been recognized as an important etiology contributing to the increased incidence of hepatocellular carcinoma (HCC). The more aggressive form, nonalcoholic steatohepatitis (NASH)...
Read MoreAdvancing the understanding of NAFLD to hepatocellular carcinoma development: From experimental models to humans.

SUBSCRIBE & FOLLOW US

SUBSCRIBE TO OUR MONTHLY NEWSLETTER TO GET THE LATEST UPDATES